Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hearing Loss | 18 | 2023 | 85 | 7.260 |
Why?
|
| Deafness | 11 | 2023 | 32 | 6.180 |
Why?
|
| Telemedicine | 8 | 2023 | 453 | 3.350 |
Why?
|
| Cochlear Implantation | 6 | 2022 | 71 | 2.150 |
Why?
|
| Hearing Loss, Noise-Induced | 2 | 2023 | 9 | 1.810 |
Why?
|
| Alaska | 8 | 2023 | 29 | 1.700 |
Why?
|
| Community Health Services | 3 | 2019 | 114 | 1.430 |
Why?
|
| Schools | 5 | 2023 | 177 | 1.370 |
Why?
|
| Education | 2 | 2019 | 46 | 1.220 |
Why?
|
| Hearing Loss, Sensorineural | 3 | 2019 | 83 | 1.180 |
Why?
|
| Rural Health Services | 2 | 2019 | 175 | 1.160 |
Why?
|
| Students | 2 | 2019 | 209 | 1.160 |
Why?
|
| School Health Services | 2 | 2023 | 52 | 1.110 |
Why?
|
| Hearing Loss, Bilateral | 2 | 2015 | 7 | 1.020 |
Why?
|
| Quality of Life | 8 | 2023 | 924 | 1.010 |
Why?
|
| Mass Screening | 4 | 2022 | 370 | 1.010 |
Why?
|
| Hearing | 4 | 2022 | 59 | 1.010 |
Why?
|
| Intelligence | 2 | 2015 | 63 | 0.990 |
Why?
|
| Hearing Tests | 2 | 2023 | 22 | 0.980 |
Why?
|
| Hemorrhagic Fever, Ebola | 2 | 2022 | 4 | 0.930 |
Why?
|
| Hearing Loss, High-Frequency | 1 | 2023 | 5 | 0.930 |
Why?
|
| Lassa Fever | 2 | 2020 | 2 | 0.910 |
Why?
|
| Referral and Consultation | 5 | 2023 | 308 | 0.860 |
Why?
|
| Child | 15 | 2023 | 7368 | 0.850 |
Why?
|
| Health Services Accessibility | 3 | 2023 | 428 | 0.810 |
Why?
|
| Cochlear Implants | 5 | 2022 | 57 | 0.780 |
Why?
|
| Humans | 40 | 2023 | 54391 | 0.780 |
Why?
|
| Cost-Benefit Analysis | 8 | 2023 | 291 | 0.760 |
Why?
|
| Prevalence | 6 | 2023 | 1025 | 0.710 |
Why?
|
| Correction of Hearing Impairment | 1 | 2019 | 5 | 0.710 |
Why?
|
| Cholesteatoma | 1 | 2019 | 6 | 0.680 |
Why?
|
| Rural Population | 5 | 2023 | 598 | 0.680 |
Why?
|
| Neurotology | 1 | 2019 | 7 | 0.680 |
Why?
|
| Ear Ossicles | 1 | 2019 | 16 | 0.680 |
Why?
|
| Eustachian Tube | 1 | 2018 | 15 | 0.660 |
Why?
|
| Ear Diseases | 1 | 2018 | 25 | 0.650 |
Why?
|
| Health Care Costs | 1 | 2019 | 175 | 0.640 |
Why?
|
| Research Design | 1 | 2020 | 375 | 0.630 |
Why?
|
| Adolescent | 10 | 2023 | 6900 | 0.600 |
Why?
|
| Audiometry, Pure-Tone | 3 | 2023 | 46 | 0.580 |
Why?
|
| Malnutrition | 1 | 2018 | 82 | 0.580 |
Why?
|
| Randomized Controlled Trials as Topic | 4 | 2023 | 594 | 0.580 |
Why?
|
| Child, Preschool | 8 | 2023 | 4158 | 0.550 |
Why?
|
| Auditory Diseases, Central | 1 | 2015 | 1 | 0.550 |
Why?
|
| Auditory Pathways | 1 | 2015 | 5 | 0.550 |
Why?
|
| beta Carotene | 1 | 2015 | 15 | 0.550 |
Why?
|
| Ascorbic Acid | 1 | 2015 | 33 | 0.540 |
Why?
|
| Neurogenesis | 1 | 2015 | 30 | 0.540 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2015 | 24 | 0.540 |
Why?
|
| Unemployment | 1 | 2015 | 16 | 0.520 |
Why?
|
| Cross-Sectional Studies | 7 | 2022 | 1696 | 0.520 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2015 | 51 | 0.520 |
Why?
|
| Audiometry | 4 | 2020 | 34 | 0.520 |
Why?
|
| Hearing Loss, Unilateral | 1 | 2015 | 12 | 0.510 |
Why?
|
| Folic Acid | 1 | 2015 | 139 | 0.510 |
Why?
|
| Primary Health Care | 1 | 2018 | 398 | 0.510 |
Why?
|
| Infant, Premature, Diseases | 1 | 2015 | 93 | 0.500 |
Why?
|
| Poverty | 2 | 2021 | 231 | 0.500 |
Why?
|
| Employment | 1 | 2015 | 95 | 0.490 |
Why?
|
| Developing Countries | 4 | 2019 | 51 | 0.480 |
Why?
|
| Vitamin A Deficiency | 1 | 2013 | 6 | 0.470 |
Why?
|
| Ear, Inner | 1 | 2013 | 18 | 0.470 |
Why?
|
| Growth Disorders | 3 | 2018 | 63 | 0.460 |
Why?
|
| Quality-Adjusted Life Years | 5 | 2023 | 70 | 0.440 |
Why?
|
| Diet | 1 | 2015 | 598 | 0.400 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 387 | 0.390 |
Why?
|
| Anti-Retroviral Agents | 1 | 2010 | 18 | 0.380 |
Why?
|
| Anti-HIV Agents | 1 | 2010 | 43 | 0.370 |
Why?
|
| Treatment Failure | 1 | 2010 | 141 | 0.370 |
Why?
|
| Multicenter Studies as Topic | 2 | 2019 | 91 | 0.340 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 325 | 0.330 |
Why?
|
| Indians, South American | 2 | 2018 | 2 | 0.320 |
Why?
|
| Nepal | 2 | 2018 | 18 | 0.290 |
Why?
|
| Vitamin A | 2 | 2018 | 18 | 0.280 |
Why?
|
| HIV Infections | 1 | 2010 | 394 | 0.280 |
Why?
|
| Child Development | 2 | 2018 | 204 | 0.280 |
Why?
|
| Hearing Aids | 2 | 2023 | 62 | 0.260 |
Why?
|
| Female | 12 | 2022 | 28471 | 0.250 |
Why?
|
| Male | 11 | 2022 | 27347 | 0.230 |
Why?
|
| Otoacoustic Emissions, Spontaneous | 1 | 2023 | 6 | 0.230 |
Why?
|
| Young Adult | 4 | 2020 | 4318 | 0.230 |
Why?
|
| Crowding | 1 | 2022 | 16 | 0.220 |
Why?
|
| Family Characteristics | 1 | 2022 | 58 | 0.220 |
Why?
|
| Socioeconomic Factors | 2 | 2015 | 639 | 0.210 |
Why?
|
| Dietary Supplements | 2 | 2018 | 457 | 0.210 |
Why?
|
| Water | 1 | 2022 | 103 | 0.210 |
Why?
|
| Qualitative Research | 1 | 2023 | 326 | 0.200 |
Why?
|
| Survivors | 1 | 2022 | 137 | 0.200 |
Why?
|
| World Health Organization | 1 | 2021 | 56 | 0.190 |
Why?
|
| Neglected Diseases | 1 | 2019 | 5 | 0.180 |
Why?
|
| Tropical Climate | 1 | 2019 | 10 | 0.180 |
Why?
|
| Asia | 1 | 2019 | 32 | 0.180 |
Why?
|
| Follow-Up Studies | 2 | 2018 | 2390 | 0.170 |
Why?
|
| Otitis Media, Suppurative | 1 | 2018 | 8 | 0.170 |
Why?
|
| Otitis Media with Effusion | 1 | 2018 | 16 | 0.170 |
Why?
|
| Infant | 4 | 2018 | 3829 | 0.160 |
Why?
|
| Medical History Taking | 1 | 2018 | 50 | 0.160 |
Why?
|
| Longitudinal Ligaments | 1 | 2018 | 3 | 0.160 |
Why?
|
| Pneumococcal Vaccines | 1 | 2018 | 10 | 0.160 |
Why?
|
| Middle Ear Ventilation | 1 | 2018 | 14 | 0.160 |
Why?
|
| Preventive Medicine | 1 | 2018 | 23 | 0.160 |
Why?
|
| Body Height | 1 | 2018 | 76 | 0.160 |
Why?
|
| Consensus | 1 | 2019 | 157 | 0.160 |
Why?
|
| Otitis Media | 1 | 2018 | 30 | 0.160 |
Why?
|
| Thinness | 1 | 2018 | 57 | 0.160 |
Why?
|
| Anthropometry | 1 | 2018 | 96 | 0.160 |
Why?
|
| Adolescent Development | 1 | 2017 | 20 | 0.150 |
Why?
|
| Indians, North American | 1 | 2018 | 38 | 0.150 |
Why?
|
| United States | 4 | 2018 | 5208 | 0.150 |
Why?
|
| Pregnancy | 2 | 2015 | 2639 | 0.150 |
Why?
|
| Gross Domestic Product | 1 | 2016 | 2 | 0.150 |
Why?
|
| Latin America | 1 | 2016 | 10 | 0.150 |
Why?
|
| Internet | 1 | 2019 | 275 | 0.140 |
Why?
|
| Africa South of the Sahara | 1 | 2015 | 4 | 0.140 |
Why?
|
| Chronic Disease | 1 | 2018 | 614 | 0.130 |
Why?
|
| Vaccination | 1 | 2018 | 298 | 0.130 |
Why?
|
| Equipment Failure | 1 | 2015 | 70 | 0.130 |
Why?
|
| Intelligence Tests | 1 | 2015 | 44 | 0.130 |
Why?
|
| Adult | 6 | 2023 | 14207 | 0.130 |
Why?
|
| Health Surveys | 1 | 2015 | 261 | 0.120 |
Why?
|
| Educational Status | 1 | 2015 | 261 | 0.120 |
Why?
|
| Middle Aged | 5 | 2023 | 13082 | 0.120 |
Why?
|
| Tretinoin | 1 | 2013 | 56 | 0.110 |
Why?
|
| Cohort Studies | 1 | 2018 | 1546 | 0.110 |
Why?
|
| Nevirapine | 1 | 2010 | 1 | 0.100 |
Why?
|
| Tanzania | 1 | 2010 | 6 | 0.100 |
Why?
|
| Alkynes | 1 | 2010 | 5 | 0.100 |
Why?
|
| CD4 Lymphocyte Count | 1 | 2010 | 35 | 0.100 |
Why?
|
| Cyclopropanes | 1 | 2010 | 19 | 0.100 |
Why?
|
| Benzoxazines | 1 | 2010 | 18 | 0.090 |
Why?
|
| HIV-1 | 1 | 2010 | 72 | 0.090 |
Why?
|
| RNA, Viral | 1 | 2010 | 141 | 0.090 |
Why?
|
| Models, Biological | 1 | 2013 | 825 | 0.090 |
Why?
|
| Aged | 3 | 2022 | 10060 | 0.090 |
Why?
|
| Risk Factors | 1 | 2018 | 3937 | 0.080 |
Why?
|
| Recurrence | 1 | 2010 | 692 | 0.080 |
Why?
|
| Bolivia | 2 | 2018 | 3 | 0.080 |
Why?
|
| Predictive Value of Tests | 1 | 2010 | 1045 | 0.070 |
Why?
|
| Severity of Illness Index | 1 | 2010 | 1082 | 0.070 |
Why?
|
| Acoustic Impedance Tests | 1 | 2023 | 8 | 0.060 |
Why?
|
| Ear, Middle | 1 | 2023 | 17 | 0.060 |
Why?
|
| Sierra Leone | 1 | 2022 | 1 | 0.060 |
Why?
|
| Uncertainty | 1 | 2022 | 43 | 0.050 |
Why?
|
| Nutrition Surveys | 1 | 2022 | 122 | 0.050 |
Why?
|
| Comparative Effectiveness Research | 1 | 2021 | 39 | 0.050 |
Why?
|
| Disease Outbreaks | 1 | 2022 | 124 | 0.050 |
Why?
|
| Organizational Objectives | 1 | 2021 | 36 | 0.050 |
Why?
|
| Lassa virus | 1 | 2020 | 1 | 0.050 |
Why?
|
| Africa, Western | 1 | 2020 | 6 | 0.050 |
Why?
|
| Infant, Newborn | 2 | 2018 | 2923 | 0.050 |
Why?
|
| Health Services Needs and Demand | 1 | 2021 | 190 | 0.040 |
Why?
|
| Community Health Workers | 1 | 2019 | 48 | 0.040 |
Why?
|
| Puberty | 1 | 2018 | 20 | 0.040 |
Why?
|
| Program Development | 1 | 2019 | 198 | 0.040 |
Why?
|
| Developed Countries | 1 | 2018 | 12 | 0.040 |
Why?
|
| Parturition | 1 | 2018 | 53 | 0.040 |
Why?
|
| Seasons | 1 | 2018 | 98 | 0.040 |
Why?
|
| Cost of Illness | 1 | 2018 | 132 | 0.040 |
Why?
|
| Incidence | 1 | 2020 | 1083 | 0.040 |
Why?
|
| Case-Control Studies | 1 | 2020 | 1229 | 0.040 |
Why?
|
| Disabled Persons | 1 | 2018 | 105 | 0.040 |
Why?
|
| Animals | 1 | 2016 | 14409 | 0.010 |
Why?
|